Cingulate Inc. vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $83 M for Cingulate Inc., 1089 times as much (market caps of Oct 28, 2026 for Cingulate Inc. and Oct 30, 2026 for Moderna, Inc.).
- Both made a net loss: $22 M for Cingulate Inc. and $2.8 B for Moderna, Inc.
Market value, the same start = 100
From Dec 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Cingulate Inc. CING · #19,456 in the world | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2010 |
| Size | ||
| Market cap | $83 M | $90.1 B |
| Revenue | — | $1.9 B |
| Net income | $-22 M▲ best | $-2.8 B |
| Employees | — | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | 33.0× | 10.4× |
| Free cash flow yield | -21.0% | -2.3%▲ best |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | -450.4% | -28.9%▲ best |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Interest cover | -22.2× | — |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Cingulate Inc. or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $83 M for Cingulate Inc., 1089 times as much (market caps of Oct 28, 2026 for Cingulate Inc. and Oct 30, 2026 for Moderna, Inc.).
Which makes more money, Cingulate Inc. or Moderna, Inc.?
Both made a net loss: $22 M for Cingulate Inc. and $2.8 B for Moderna, Inc.
More about Cingulate Inc.
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.